Alessandro N, 2009, Pharm Res, 26, 1918, 10.1007/s11095-009-9908-0
10.1016/S0168-3659(97)00136-3
Bedows E, 1982, J Nat Prod, 45, 725, 10.1021/np50024a015
Cui FY, 2006, Int J Pharm, 316, 154, 10.1016/j.ijpharm.2006.02.031
De Campos AM, 2001, Application to cyclosporin A. Int J Pharm, 224, 159
Desbene S, 2002, Curr Med Chem Anti-Cancer Agents, 2, 71, 10.2174/1568011023354353
Gordaliza M, 1996, J Med Chem, 39, 2865, 10.1021/jm960023h
Gordaliza M, 2004, Toxicon, 44, 441, 10.1016/j.toxicon.2004.05.008
Hu FQ, 2009, Biomaterials, 30, 6955, 10.1016/j.biomaterials.2009.09.008
Hu FQ, 2006, Colloids Surf B – Biointerfaces, 50, 97, 10.1016/j.colsurfb.2006.04.009
Hu FQ, 2006, Int J Pharm, 315, 158, 10.1016/j.ijpharm.2006.02.026
Imbert TF, 1998, Biochimie, 80, 207, 10.1016/S0300-9084(98)80004-7
Kim SY, 1998, Micelle formation and drug release behaviours. J Control Rel, 51, 13, 10.1016/S0168-3659(97)00124-7
Lee KY, 1998, J Control Rel, 51, 213, 10.1016/S0168-3659(97)00173-9
Longstaff E, 2001, Regul Toxicol Pharm, 33, 117, 10.1006/rtph.2000.1446
Lopez-Perez JL, 2004, Bioorg Med Chem Lett, 14, 1283, 10.1016/j.bmcl.2003.12.039
Qin L, 2010, Int J Pharm, 388, 223, 10.1016/j.ijpharm.2009.12.044
Takeshi K, 2010, Anticancer Res, 30, 3151
10.1080/10611860600648346
Varum KM, 2001, Carbohydr Polym, 46, 89, 10.1016/S0144-8617(00)00288-5
Vladimir L, 1998, Anal Biochem, 264, 185, 10.1006/abio.1998.2837
Ye YQ, 2008, Int J Pharm, 352, 294, 10.1016/j.ijpharm.2007.10.035
You J, 2007, Biomacromolecules, 8, 2450, 10.1021/bm070365c
Zhu RR, 2009, Nanotechnology, 20, 55702, 10.1088/0957-4484/20/5/055702
